Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Inks Forensic Services Deal with Kenyon

NEW YORK, Feb. 9 (GenomeWeb News) - Orchid will provide forensic DNA testing services to customers of the disaster management company Kenyon International Emergency Services, Orchid said today.

 

Financial details of the agreement were not disclosed.

 

Houston-based Kenyon has provided emergency services since 1929, including mortuary services for victims of the Sept. 11, 2001, terrorist attacks in the United States, the Asian tsunami of 2004, and Hurricane Katrina.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.